Equities
  • Price (BRL)2,037.04
  • Today's Change0.00 / 0.00%
  • Shares traded30.00
  • 1 Year change+26.42%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 20:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ACN:NYQ since
announced
Transaction
value
Allitix IncDeal completed04 Nov 202404 Nov 2024Deal completed4.45%--
Joshua Tree Group LLCDeal completed14 Oct 202414 Oct 2024Deal completed0.09%--
Consus.Health GmbHAnnounced27 Aug 202427 Aug 2024Announced7.21%--
Boslan Ingenieria Y Consultoria SADeal completed02 Aug 202402 Aug 2024Deal completed10.05%--
Camelot Management Consultants AGAnnounced22 Jul 202422 Jul 2024Announced9.68%--
Data delayed at least 15 minutes, as of Nov 22 2024.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Western Asset Management Company DTVM Ltda.as of 30 Jun 202410.96k0.00%
BRAM - Bradesco Asset Management SA DTVMas of 30 Jun 20241.38k0.00%
Pennsylvania State Employees' Retirement Systemas of 31 Dec 20230.000.00%
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.